MPS Pharmaa informs about statement of investor complaints

11 Oct 2024 Evaluate
As per the requirements of Regulation 13(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, MPS Pharmaa has informed that it enclosed Statement of Investor Complaints for the quarter ended 30th September, 2024.

The above information is a part of company’s filings submitted to BSE.

MPS Pharmaa Share Price

1.68 0.00 (0.00%)
12-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×